GeneDx selected by Florida State University as partner for Sunshine Genetics Act

GeneDx (WGS) announced Florida State University has selected GeneDx as one of its partners for the recently passed Sunshine Genetics Act, an initiative establishing the nation’s first state-backed genomic newborn screening program. The Sunshine Genetics program, a five-year pilot program, will offer whole-genome sequencing for newborns at select academic medical centers and hospitals, providing families and clinicians the opportunity for early detection and diagnosis of rare diseases. Under the Sunshine Genetics Act, Florida becomes the first state to offer genomic newborn screening for hundreds of diseases, marking a historic expansion from research to the standard of care. The program’s goal is to sequence 100,000 newborns.